Table 7.
Pregnancy outcomes
| Characteristic | All (N=64) | Severe group (n=44) | Critical group (n=20) | P value |
|---|---|---|---|---|
| Steroids for fetal maturity | 16 (25) | 7 (16) | 9 (45) | .013 |
| Magnesium sulfate for neuroprotection | 6 (9) | 0 (0) | 6 (30) | .001 |
| Hypertensive disorders of pregnancy | 2 (3) | 2 (5) | 0 (0) | 1.00 |
| Magnesium sulfate for preeclampsia | 1 (2) | 1 (2) | 0 (0) | 1.00 |
| IUGR | 2 (3) | 0 (0) | 2 (10) | .094 |
| Stillbirth | 0 (0) | 0 (0) | 0 (0) | 1.00 |
| Oligohydramnios | 1 (2) | 1 (2) | 0 (0) | 1.00 |
| Delivered with COVID-19 during hospitalization (any cause) | 32 (50) | 15 (34) | 17 (85) | <.001 |
| Delivered for maternal status | 22 (69) | 9 (60) | 13 (76) | .32 |
| Delivered for fetal status | 3 (9) | 0 (0) | 3 (18) | .23 |
| Delivered for obstetrical indications | 7 (22) | 6 (40) | 1 (6) | .033 |
| Presumed chorioamnionitis or endometritis | 3 (9) | 3 (20) | 0 (0) | .092 |
| Postpartum hemorrhagea | 3 (9) | 2 (13) | 1 (6) | 0.590 |
| Preterm delivery at <37 wk | 19 (59) | 4 (27) | 15 (88) | .001 |
| Preterm delivery at <34 wk | 10 (31) | 0 (0) | 10 (59) | <.0001 |
| Spontaneous preterm labor | 2 (6) | 0 (0) | 2 (12) | .49 |
| PPROM | 1 (3) | 1 (7) | 0 (0) | .47 |
| Delivery route | ||||
| Vaginal (includes operative vaginal delivery) | 8 (25) | 7 (47) | 1 (6) | .009 |
| Cesarean delivery | 24 (75) | 8 (53) | 16 (94) | |
Data are presented as n (%).
COVID-19, coronavirus disease 2019; IUGR, intrauterine growth restriction; PPROM, preterm premature rupture of membranes.
Pierce-Williams et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies. AJOG MFM 2020.
a
Postpartum hemorrhage is defined as an estimated blood loss of ≥1000 mL with noticeable symptoms of blood loss/vital sign changes.